Vaishali Sanchorawala | Profiles RNS

Vaishali Sanchorawala, MD Hear my name

Professor

Boston University Chobanian & Avedisian School of Medicine

Dept of Medicine

Hematology & Medical Oncology

MBBS, Seth G.S. Medical College

Pronouns: she/her/hers

Websites

	Boston Medical Center Provider Profile
	Amyloidosis Center
	LinkedIn
	ResearchGate

ORCID : 0000-0002-6307-2445

72 East Concord Street, K-503, Boston, MA 02118
820 Harrison Avenue, Boston, MA 02118 (clinic address)

Expertise includes: AL amyloidosis - clinical trials, treatment; Amyloidosis; Stem cell transplantation; Myeloma.

Dr Vaishali Sanchorawala is the Director of Stem Cell Transplantation program at Boston Medical Center; Director of Amyloidosis Center at Chobanian and Avedisian School of Medicine; Skinner Professor of Amyloidosis Research in the Department of Medicine; Associate Editor of Amyloid: The Journal of Protein Folding Disorders and Secretary of the International Society of Amyloidosis for the term 2020-2022.

Her research has led and defined the field in AL amyloidosis. She is recognized as one of the leading international experts and a key opinion leader in amyloidosis. With numerous publications and meeting presentations, she is one of the pioneers in the field of clinical research in AL amyloidosis. Her work in the treatment of AL amyloidosis has resulted in the evolution of the standard of care for these patients. I am currently heading several clinical trials in the treatment of AL amyloidosis, two of which were conducted nationally through the Southwest Oncology Group (SWOG0115 and SWOG1702), completed accrual in a timely fashion and led to publications in a peer-reviewed journals.

Dr Sanchorawala is part of the faculty at major international conferences in amyloidosis and has given many invited talks at national and international meetings. She is active in various non-profit organizations, regulatory authorities, and funding bodies as an expert on amyloidosis. She is at present a member of the Executive Steering Committee of Amyloidosis Research Consortium which is developing pathways to education, patient voice, development of treatment and access to novel therapies. She has participated in meetings with the FDA for enhancing the amyloidosis drug development pathway, guidance for more efficient and successful programs. She serves on the advisory board of number of leading pharmaceutical partners for drugs in AL amyloidosis.

She has helped to create and cultivate the next generation of physician-scientists in the area of clinical research in amyloidosis. She regularly attends a number of patient information seminars and support group meetings in the US. She also created the first “live tweet event” for patients and care givers to ask questions via social media.

Outside of roles of direct research and clinical care, she has an interest inworking in charity organizations. She helps cook meals for ~300 underserved individuals at a meal center in Massachusetts (1-2 times a month) and volunteers regularly at “Cradles to Crayons” charity, non-profit organization.

Diversity, Equity, Inclusion and Accessibility

I stand firmly committed to diversity, equity, inclusion, and justice as a core value of my professional and personal life. I have a strong commitment to making a difference to people from underprivileged and marginalized communities. I strive to bridge access to the most cutting-edge diagnostic modalities and treatments for members of all underrepresented groups—e.g., ethnic, racial, religious, and sexual minorities, among others.

I also support diversity and equity through my research efforts, by studying racial and ethnic inequalities that are pervasive within the field of medicine. In particular, I am struck by the low representation of minorities in clinical trials, despite having a disproportionately higher risk of certain diseases. I mentored a fellow to conduct a study investigating racial and ethnic disparities in a rare plasma cell disorder called AL amyloidosis, and found that differences in health outcomes among minorities were largely explained by lower educational level and later recognition of disease, rather than race and ethnicity itself. We concluded that, in order to mitigate disparities in this rare disease, earlier disease detection and concerted efforts to reduce economic and/or language barriers are key.

My influence extends beyond the groundbreaking and paradigm-shifting work in the field of amyloidosis. In addition to my scientific achievements, I have an interest in working in charity organizations. I help cook meals for ~300 underserved individuals at a meal center in Massachusetts (1-2 times a month) and volunteer regularly at “Cradles to Crayons” charity, non-profit organization. I consistently seek opportunities to understand, respect and serve communities in need.

Associate Director
Boston University Chobanian & Avedisian School of Medicine
Amyloidosis Center

Member
Boston University
BU-BMC Cancer Center

Director
Boston Medical Center
Stem Cell Transplantation Program
Hematology & Medical Oncology

Secretary
International Society of Amyloidosis

Executive committee
Amyloidosis Research Consortium

Associate Editor
Amyloid: The Journal of Protein Folding disorders

BU Research
BMC Research

Evaluating Plasma Neurofilament Light Chain as an Early Biomarker for Polyneuropathy in V122I Hereditary Transthyretin Amyloidosis
01/01/2022 - 12/31/2022 (Key Person / Mentor)
PI: K. H. Vincent Lau, MD
Amyloidosis Foundation

A phase 3 randomized, controlled, open-label, multicenter, safety and efficacy study of dexamethasone plus MLN9708 or physician's choice of treatment administered to patients with relapsed or refracto
09/28/2012 - 09/27/2022 (PI)
Millennium Pharmaceuticals, Inc.

Defining a molecular signature of cardiac tissue dysfunction in systemic immunoglobulin light-chain amyloidosis
07/01/2020 - 06/30/2022 (Key Person / Mentor)
PI: Camille Edwards, MD
American Society of Hematology

SPORE in Multiple Myeloma
06/01/2021 - 05/31/2022 (Key Person / Mentor)
Dana-Farber Cancer Institute NIH NCI
5P50CA100707-18

A Phase I/II Trial of Pomalidomide and Dexamethasone for the treatment of patients with AL Amyloidosis
03/01/2012 - 02/28/2021 (PI)
Celgene Corporation

Molecular Imaging of Primary Amyloid Cardiomyopathy
04/01/2017 - 03/31/2020 (Co-Investigator)
The Brigham and Women's Hospital, Inc. NIH NHLBI
5R01HL130563-04

A Phase I Dose-Escalation Study of Carflizomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
12/12/2013 - 12/12/2019 (PI)
Academic Myeloma Consortium

Phase II study of the combination Bendamustine and Dexamethasone in patients with relapsed AL amyloidosis
09/04/2012 - 09/09/2019 (Subcontract PI)
Trustees Of Columbia University In The City Of New York Cephalon, Inc

A phase 1, open label, dose escalation study of intravenous administration of single agent NEOD001 in subjects with light chain (AL) amyloidosis
05/08/2013 - 05/07/2019 (PI)
Onclave Therapeutics Limited, d/b/a Prothena Therapeutics Limited

An Open-Label, Dose-Escalation, Phase 1 Study of the Oral Formulation of MLN9708 Administered Weekly in Adult Patients with Relapsed or Refractory Light-Chain (AL) Amyloidosis Who Require Further
04/01/2011 - 03/03/2019 (PI)
Millennium Pharmaceuticals, Inc.

Showing 10 of 17 results. Show All Results

CAEL-101 301: A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment Versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment-Naïve Patients with Mayo Sta
09/23/2020 - 09/30/2040 (PI)
Caelum Biosciences, Inc.

CAEL-101 302: A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment Versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment-Naïve Patients with Mayo Sta
09/23/2020 - 09/30/2040 (PI)
Caelum Biosciences, Inc.

NEOD001-301: A Phase 3, Randomized, Multicenter, Double-Blin
06/23/2021 - 06/22/2024 (PI)
Prothena Biosciences Limited

STI-6129-001: A Phase 1, Open-Label, Dose-Escalation Study of the Safety and Efficacy of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients with Relapsed or Refractory Systemic AL Amyloidosis
12/01/2020 - 11/30/2023 (PI)
Sorrento Therapeutics, Inc.

A Phase II randomized single-blind study to evaluate the activity and safety of low dose oral…
04/23/2020 - 04/22/2023 (PI)
Karyopharm Therapeutics Inc.

DARATUMUMAB, POMALIDOMIDE AND DEXAMETHASONE (DPd) IN RELAPSED/ REFRACTORY LIGHT CHAIN AMYLOIDOSIS PATIENTS PREVIOUSLY EXPOSED TO DARATUMUMAB
07/23/2020 - 01/22/2023 (PI)
Weill Cornell Medical College Janssen Scientific A

DFCI 19-291: A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone…
12/23/2019 - 12/22/2022 (PI)
Dana Farber Millennium Pharmaceu

Oncopeptides: An Open-Label, Phase 1/2 Study of Melflufen and Dexamethasone for Patients with AL…
11/21/2019 - 11/20/2022 (PI)
Oncopeptides AB

54767414AMY3001
11/17/2017 - 11/17/2022 (PI)
Janssen Research and Development, LLC

54767414MMY3019 DARA
04/15/2019 - 04/15/2022 (PI)
Janssen Scientific Affairs LLC

Showing 10 of 15 results. Show All Results

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Wechalekar AD, Sanchorawala V. Daratumumab in AL amyloidosis. Blood. 2022 Dec 01; 140(22):2317-2322. PMID: 35507692

Wechalekar AD, Cibeira MT, Gibbs SD, Jaccard A, Kumar S, Merlini G, Palladini G, Sanchorawala V, Schönland S, Venner C, Boccadoro M, Kastritis E. Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group. Amyloid. 2022 Jul 15; 1-15. PMID: 35838162

Gustine JN, Staron A, Szalat RE, Mendelson LM, Joshi T, Ruberg FL, Siddiqi O, Gopal DM, Edwards CV, Havasi A, Kaku M, Lau KHV, Berk JL, Sloan JM, Sanchorawala V. Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. Am J Hematol. 2022 Sep; 97(9):1189-1199.View Related Profiles.

Staron, Andrew
Edwards, Camille
Gopal, Deepa
Ruberg, Frederick
Sloan, J.
Berk, John
Lau, K.H. Vincent
Mendelson, Lisa
Kaku, Michelle
Siddiqi, Omar
Szalat, Raphael
Joshi, Tracy
Sanchorawala, Vaishali

PMID: 35731907

Staron A, Zheng L, Doros G, Sanchorawala V. Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans. Blood Cancer J. 2022 07 04; 12(7):100.View Related Profiles.

Staron, Andrew
Doros, Gheorghe
Sanchorawala, Vaishali

PMID: 35787622; PMCID: PMC9253332; DOI: 10.1038/s41408-022-00697-3;

Nader R, Zhen A, Angel-Korman A, Pavlovich SS, Pogrebinsky A, Doros G, Menn-Josephy H, Stern L, Sanchorawala V, Havasi A. Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis. Nephrol Dial Transplant. 2022 Jun 23; 37(7):1281-1288.View Related Profiles.

Zhen, Aileen
Havasi, Andrea
Doros, Gheorghe
Menn-Josephy, Hanni
Stern, Lauren
Nader, Ralph
Sanchorawala, Vaishali

PMID: 34043009

Prokaeva T, Joshi T, Klimtchuk ES, Gibson VM, Spencer B, Siddiqi O, Nedelkov D, Hu Y, Berk JL, Cuddy SAM, Dasari S, Chiu A, Choate LA, McPhail ED, Cui H, Chen H, Burks EJ, Sanchorawala V, Connors LH. A novel substitution of proline (P32L) destabilises ß2-microglobulin inducing hereditary systemic amyloidosis. Amyloid. 2022 Dec; 29(4):255-262.View Related Profiles.

Klimtchuk, Elena
Burks, Eric
Chen, Hui
Berk, John
Connors, Lawreen
Siddiqi, Omar
Prokaeva, Tatiana
Joshi, Tracy
Sanchorawala, Vaishali

PMID: 35575118; DOI: 10.1080/13506129.2022.2072199;

Staron A, Verma K, Sanchorawala V. Prevalence of plasma cell and lymphoproliferative disorders among blood relatives of patients with light chain amyloidosis. Br J Haematol. 2022 Sep; 198(5):861-865.View Related Profiles.

Staron, Andrew
Sanchorawala, Vaishali

PMID: 35499208

Sanchorawala V, Palladini G, Minnema MC, Jaccard A, Lee HC, Gibbs S, Mollee P, Venner C, Lu J, Schönland S, Gatt M, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Chauveau D, Gries KS, Fastenau J, Tran NP, Qin X, Vasey SY, Weiss BM, Vermeulen J, Ho KF, Merlini G, Comenzo RL, Kastritis E, Wechalekar AD. Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone?±?daratumumab: Results from the ANDROMEDA study. Am J Hematol. 2022 Jun 01; 97(6):719-730. PMID: 35293006

Hughes DM, Henshaw L, Blevins F, Edwards C, Lerner A, Sloan JM, Sanchorawala V. Standard 30-minute Monitoring Time and Less Intensive Pre-medications is Safe in Patients Treated With Subcutaneous Daratumumab for Multiple Myeloma and Light Chain Amyloidosis. Clin Lymphoma Myeloma Leuk. 2022 Aug; 22(8):566-568.View Related Profiles.

Lerner, Adam
Edwards, Camille
Hughes, David
Arters, Frances
Sloan, J.
Sanchorawala, Vaishali

PMID: 35367193

Kaku MC, Bhadola S, Berk JL, Sanchorawala V, Connors LH, Lau KHV. Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays. Amyloid. 2022 Sep; 29(3):184-189.View Related Profiles.

Berk, John
Lau, K.H. Vincent
Connors, Lawreen
Kaku, Michelle
Bhadola, Shivkumar
Sanchorawala, Vaishali

PMID: 35253562

Showing 10 of 217 results. Show More

Milrod CJ, Mann M, Blevins F, Hughes D, Patel P, Li KY, Lerner A, Sanchorawala V, Sloan JM. Underrepresentation of Black participants and adverse events in clinical trials of lenalidomide for myeloma. Crit Rev Oncol Hematol. 2022 Apr; 172:103644.View Related Profiles.

Lerner, Adam
Milrod, Charles
Arters, Frances
Sloan, J.
Sanchorawala, Vaishali

PMID: 35227897; DOI: 10.1016/j.critrevonc.2022.103644;

Mendelson L, Sanchorawala V, Connors L, Joshi T, Doros G, Pogrebinsky A, Havasi A. Correlation Between 24-Hour Urine Protein and Random Urine Protein-Creatinine Ratio in Amyloid Light-Chain Amyloidosis. Kidney Med. 2022 Apr; 4(4):100427.View Related Profiles.

Doros, Gheorghe
Connors, Lawreen
Mendelson, Lisa
Joshi, Tracy
Sanchorawala, Vaishali

PMID: 35342879; PMCID: PMC8942830; DOI: 10.1016/j.xkme.2022.100427;

Sanchorawala V. Summary of the EHA-ISA Working Group Guidelines for High-dose Chemotherapy and Stem Cell Transplantation for Systemic AL Amyloidosis. Hemasphere. 2022 Feb; 6(2):e681. PMID: 35106451; PMCID: PMC8797507; DOI: 10.1097/HS9.0000000000000681;

Abdallah M, Sanchorawala V. Update on the Contemporary Treatment of Light Chain Amyloidosis Including Stem Cell Transplantation. Am J Med. 2022 Apr; 135 Suppl 1:S30-S37.View Related Profiles.

Abdallah, Maya
Sanchorawala, Vaishali

PMID: 35081382

Cuddy SAM, Jerosch-Herold M, Falk RH, Kijewski MF, Singh V, Ruberg FL, Sanchorawala V, Landau H, Maurer MS, Yee AJ, Bianchi G, Di Carli MF, Liao R, Kwong RY, Dorbala S. Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful Therapy. JACC Cardiovasc Imaging. 2022 Apr; 15(4):594-603.View Related Profiles.

Ruberg, Frederick
Sanchorawala, Vaishali

PMID: 34922860; PMCID: PMC8995332; DOI: 10.1016/j.jcmg.2021.09.032;

Furtado VF, Brauneis D, Weinberg J, Elhassan N, Sloan JM, Sanchorawala V. Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis. Bone Marrow Transplant. 2022 02; 57(2):306-308.View Related Profiles.

Sloan, J.
Weinberg, Janice
Sanchorawala, Vaishali

PMID: 34845368

Sanchorawala V, Boccadoro M, Gertz M, Hegenbart U, Kastritis E, Landau H, Mollee P, Wechalekar A, Palladini G. Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines. Amyloid. 2022 Mar; 29(1):1-7. PMID: 34783272

Szalat RE, Gustine J, Sloan JM, Edwards CV, Sanchorawala V. Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab. Am J Hematol. 2022 01 01; 97(1):79-89.View Related Profiles.

Edwards, Camille
Sloan, J.
Szalat, Raphael
Sanchorawala, Vaishali

PMID: 34739735

Staron A, Zheng L, Doros G, Connors LH, Mendelson LM, Joshi T, Sanchorawala V. Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study. Blood Cancer J. 2021 08 04; 11(8):139.View Related Profiles.

Staron, Andrew
Doros, Gheorghe
Connors, Lawreen
Mendelson, Lisa
Joshi, Tracy
Sanchorawala, Vaishali

PMID: 34349108; PMCID: PMC8338947; DOI: 10.1038/s41408-021-00529-w;

Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis. N Engl J Med. 2021 07 01; 385(1):46-58. PMID: 34192431

Dispenzieri A, Kastritis E, Wechalekar AD, Schönland SO, Kim K, Sanchorawala V, Landau HJ, Kwok F, Suzuki K, Comenzo RL, Berg D, Liu G, Kumar A, Faller DV, Merlini G. A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis. Leukemia. 2022 01; 36(1):225-235. PMID: 34168284; PMCID: PMC8727292; DOI: 10.1038/s41375-021-01317-y;

Sarosiek S, Varga C, Jacob A, Fulciniti MT, Munshi N, Sanchorawala V. Detection of minimal residual disease by next generation sequencing in AL amyloidosis. Blood Cancer J. 2021 06 21; 11(6):117.View Related Profiles.

Munshi, Nikhil C.
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 34155198; PMCID: PMC8217177; DOI: 10.1038/s41408-021-00511-6;

Milrod CJ, Blevins F, Hughes D, Lerner A, Sarosiek S, Sanchorawala V, Sloan JM. Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs. Blood. 2021 05 27; 137(21):2987-2989.View Related Profiles.

Lerner, Adam
Milrod, Charles
Arters, Frances
Sloan, J.
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 33728443

Benbrahim M, Norman K, Sanchorawala V, Siddiqi OK, Hughes D. A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis. J Cardiovasc Pharmacol. 2021 05 01; 77(5):544-548.View Related Profiles.

Siddiqi, Omar
Sanchorawala, Vaishali

PMID: 33657048

Acevedo J, Doros G, Szalat R, Sanchorawala V. Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL Amyloidosis. Clin Lymphoma Myeloma Leuk. 2021 06; 21(6):425-426.View Related Profiles.

Doros, Gheorghe
Acevedo, Jose
Szalat, Raphael
Sanchorawala, Vaishali

PMID: 33622658

Premkumar VJ, Lentzsch S, Pan S, Bhutani D, Richter J, Jagannath S, Liedtke M, Jaccard A, Wechalekar AD, Comenzo R, Sanchorawala V, Royer B, Rosenzweig M, Valent J, Schönland S, Fonseca R, Wong S, Kapoor P. Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. Blood Cancer J. 2021 01 11; 11(1):10. PMID: 33431806; PMCID: PMC7801694; DOI: 10.1038/s41408-020-00397-w;

Palladini G, Schönland SO, Sanchorawala V, Kumar S, Wechalekar A, Hegenbart U, Milani P, Ando Y, Westermark P, Dispenzieri A, Merlini G. Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis. Amyloid. 2021 Mar; 28(1):1-2. PMID: 33410355

Lovley A, Raymond K, Guthrie SD, Pollock M, Sanchorawala V, White MK. Patient-reported burden of hereditary transthyretin amyloidosis on functioning and well-being. J Patient Rep Outcomes. 2021 Jan 07; 5(1):3. PMID: 33411323; PMCID: PMC7790957; DOI: 10.1186/s41687-020-00273-y;

Hughes DM, DeMari S, Hassan H, Sanchorawala V, Sloan JM. Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis. Clin Lymphoma Myeloma Leuk. 2021 05; 21(5):e460-e463.View Related Profiles.

Hughes, David
Hassan, Hamza
Sloan, J.
Sanchorawala, Vaishali

PMID: 33716055

Lohrmann G, Patel MA, Brauneis D, Sanchorawala V, Sarosiek S, Vellanki N, Siddiqi OK, Ruberg FL, Gopal DM. Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell Transplantation. JACC CardioOncol. 2020 Dec; 2(5):721-731.View Related Profiles.

Gopal, Deepa
Ruberg, Frederick
Siddiqi, Omar
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 33511355; PMCID: PMC7839967; DOI: 10.1016/j.jaccao.2020.10.010;

Staron A, Connors LH, Zheng L, Doros G, Sanchorawala V. Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities. Blood Cancer J. 2020 11 10; 10(11):118.View Related Profiles.

Staron, Andrew
Doros, Gheorghe
Connors, Lawreen
Sanchorawala, Vaishali

PMID: 33173025; PMCID: PMC7655813; DOI: 10.1038/s41408-020-00385-0;

Hughes DM, Staron A, Sanchorawala V. A pharmacist's review of the treatment of systemic light chain amyloidosis. J Oncol Pharm Pract. 2021 Jan; 27(1):187-198.View Related Profiles.

Staron, Andrew
Hughes, David
Sanchorawala, Vaishali

PMID: 33028132

Law ST, Jafarzadeh SR, Govender P, Sun X, Sanchorawala V, Kissin EY. Comparison of Ultrasound Features of Major Salivary Glands in Sarcoidosis, Amyloidosis, and Sjögren's Syndrome. Arthritis Care Res (Hoboken). 2020 10; 72(10):1466-1473.View Related Profiles.

Kissin, Eugene
Govender, Praveen
Jafarzadeh, S. Reza
Sanchorawala, Vaishali

PMID: 31309727

Hoffman JE, Dempsey NG, Sanchorawala V. Systemic Amyloidosis Caused by Monoclonal Immunoglobulins: Soft Tissue and Vascular Involvement. Hematol Oncol Clin North Am. 2020 12; 34(6):1099-1113. PMID: 33099427

Sarosiek S, Zheng L, Sloan JM, Quillen K, Brauneis D, Sanchorawala V. Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis. Blood Cancer J. 2020 09 01; 10(8):88.View Related Profiles.

Sloan, J.
Quillen, Karen
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 32873776; PMCID: PMC7462849; DOI: 10.1038/s41408-020-00354-7;

Szalat R, Sarosiek S, Havasi A, Brauneis D, Sloan JM, Sanchorawala V. Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis. Leukemia. 2021 03; 35(3):916-919.View Related Profiles.

Havasi, Andrea
Sloan, J.
Szalat, Raphael
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 32737434

Schulman A, Connors LH, Weinberg J, Mendelson LM, Joshi T, Shelton AC, Sanchorawala V. Patient outcomes in light chain (AL) amyloidosis: The clock is ticking from symptoms to diagnosis. Eur J Haematol. 2020 Oct; 105(4):495-501.View Related Profiles.

Weinberg, Janice
Connors, Lawreen
Mendelson, Lisa
Joshi, Tracy
Sanchorawala, Vaishali

PMID: 32564450; DOI: 10.1111/ejh.13472;

Kastritis E, Wechalekar A, Schönland S, Sanchorawala V, Merlini G, Palladini G, Minnema M, Roussel M, Jaccard A, Hegenbart U, Kumar S, Cibeira MT, Blade J, Dimopoulos MA. Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic. Br J Haematol. 2020 08; 190(3):346-357. PMID: 32480420; PMCID: PMC7300844; DOI: 10.1111/bjh.16898;

Palladini G, Kastritis E, Maurer MS, Zonder J, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Bumma N, Kaufman JL, Medvedova E, Kovacsovics T, Rosenzweig M, Sanchorawala V, Qin X, Vasey SY, Weiss BM, Vermeulen J, Merlini G, Comenzo RL. Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA. Blood. 2020 07 02; 136(1):71-80. PMID: 32244252; PMCID: PMC7332897; DOI: 10.1182/blood.2019004460;

Dumas B, Yameen H, Sarosiek S, Sloan JM, Sanchorawala V. Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen. Amyloid. 2020 Dec; 27(4):244-249.View Related Profiles.

Sloan, J.
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 32551974

Mendelson L, Shelton A, Brauneis D, Sanchorawala V. AL Amyloidosis in Myeloma: Red Flag Symptoms. Clin Lymphoma Myeloma Leuk. 2020 11; 20(11):777-778.View Related Profiles.

Mendelson, Lisa
Sanchorawala, Vaishali

PMID: 32631780; DOI: 10.1016/j.clml.2020.05.023;

Cuddy SAM, Bravo PE, Falk RH, El-Sady S, Kijewski MF, Park MA, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Cheng SC, Jerosch-Herold M, Kwong RY, Liao R, Dorbala S. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging. 2020 06; 13(6):1325-1336.View Related Profiles.

Ruberg, Frederick
Sanchorawala, Vaishali

PMID: 32417333; PMCID: PMC8218539; DOI: 10.1016/j.jcmg.2020.02.025;

Sanchorawala V, Sarosiek S, Schulman A, Mistark M, Migre ME, Cruz R, Sloan JM, Brauneis D, Shelton AC. Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study. Blood. 2020 04 30; 135(18):1541-1547.View Related Profiles.

Sloan, J.
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 31978210; PMCID: PMC7193185; DOI: 10.1182/blood.2019004436;

Sanchorawala V. High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis. Acta Haematol. 2020; 143(4):381-387. PMID: 32248194

Lerner G, Moradi S, Cohen-Bucay A, Chen H, Sanchorawala V, Gordon CE, Henderson JM. Coincidental crystalline light chain cast nephropathy, light chain proximal tubulopathy, and urine crystallopathy: A case report and review of the literature?. Clin Nephrol. 2020 Apr; 93(4):203-208.View Related Profiles.

Henderson, Joel
Sanchorawala, Vaishali

PMID: 31907143

Staron A, Burks EJ, Lee JC, Sarosiek S, Sloan JM, Sanchorawala V. Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis. Blood Adv. 2020 03 10; 4(5):880-884.View Related Profiles.

Staron, Andrew
Burks, Eric
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 32130406; PMCID: PMC7065470; DOI: 10.1182/bloodadvances.2019001331;

Angel-Korman A, Stern L, Angel Y, Sarosiek S, Menn-Josephy H, Francis J, Ghai S, Sloan JM, Sanchorawala V, Havasi A. The Role of Kidney Transplantation in Monoclonal Ig Deposition Disease. Kidney Int Rep. 2020 Apr; 5(4):485-493.View Related Profiles.

Havasi, Andrea
Menn-Josephy, Hanni
Sloan, J.
Francis, Jean
Stern, Lauren
Ghai, Sandeep
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 32274452; PMCID: PMC7136323; DOI: 10.1016/j.ekir.2020.01.011;

Lentzsch S, Lagos GG, Comenzo RL, Zonder JA, Osman K, Pan S, Bhutani D, Pregja S, Sanchorawala V, Landau H. Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study. J Clin Oncol. 2020 05 01; 38(13):1455-1462. PMID: 32083996; PMCID: PMC7193746; DOI: 10.1200/JCO.19.01721;

Khor YM, Cuddy S, Harms HJ, Kijewski MF, Park MA, Robertson M, Hyun H, Di Carli MF, Bianchi G, Landau H, Yee A, Sanchorawala V, Ruberg FL, Liao R, Berk J, Falk RH, Dorbala S. Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. Eur J Nucl Med Mol Imaging. 2020 07; 47(8):1998-2009.View Related Profiles.

Ruberg, Frederick
Berk, John
Sanchorawala, Vaishali

PMID: 31807884; PMCID: PMC8202062; DOI: 10.1007/s00259-019-04627-7;

Staron A, Kataria Y, Murray DL, Sloan JM, Sanchorawala V. Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes. Am J Hematol. 2020 02; 95(2):E45-E48.View Related Profiles.

Staron, Andrew
Sloan, J.
Sanchorawala, Vaishali
Kataria, Yachana

PMID: 31736101

Sarosiek S, Sanchorawala V. Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives. J Blood Med. 2019; 10:373-380.View Related Profiles.

Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 31695543; PMCID: PMC6815750; DOI: 10.2147/JBM.S183857;

Angel-Korman A, Jaberi A, Sanchorawala V, Havasi A. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis. Amyloid. 2020 Mar; 27(1):17-24.View Related Profiles.

Jaberi, Aala
Havasi, Andrea
Sanchorawala, Vaishali

PMID: 31595786; PMCID: PMC6960349; DOI: 10.1080/13506129.2019.1672650;

Gupta VK, White PS, Brauneis D, Shelton AC, Quillen K, Sanchorawala V, Sarosiek S, Sloan JM. Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients. Am J Hematol. 2019 12; 94(12):E317-E319.View Related Profiles.

Sloan, J.
Quillen, Karen
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 31489689

Lilleness B, Doros G, Ruberg FL, Sanchorawala V. Establishment of brain natriuretic peptide - based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosis. Br J Haematol. 2020 02; 188(3):424-427.View Related Profiles.

Ruberg, Frederick
Doros, Gheorghe
Sanchorawala, Vaishali

PMID: 31515797

Pudusseri A, Sanchorawala V, Sloan JM, Bever KM, Doros G, Kataria S, Sarosiek S. Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosis. Am J Hematol. 2019 10; 94(10):1098-1103.View Related Profiles.

Doros, Gheorghe
Sloan, J.
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 31292986

Staron A, Connors LH, Ruberg FL, Mendelson LM, Sanchorawala V. A new era of amyloidosis: the trends at a major US referral centre. Amyloid. 2019 Dec; 26(4):192-196.View Related Profiles.

Staron, Andrew
Ruberg, Frederick
Connors, Lawreen
Mendelson, Lisa
Sanchorawala, Vaishali

PMID: 31306033

Qualls DA, Lewis GD, Sanchorawala V, Staron A. Orthotopic heart transplant rejection in association with immunomodulatory therapy for AL amyloidosis: A case series and review of the literature. Am J Transplant. 2019 11; 19(11):3185-3190.View Related Profiles.

Staron, Andrew
Sanchorawala, Vaishali

PMID: 31207062

Sanchorawala V, Doros G, Shelton AC. Long term outcome of patients treated on clinical trials of immunomodulatory agents for the treatment of Immunoglobulin light chain (AL) amyloidosis: A pooled analysis. Am J Hematol. 2019 07; 94(7):E194-E196.View Related Profiles.

Doros, Gheorghe
Sanchorawala, Vaishali

PMID: 31020691

Ehman EC, El-Sady MS, Kijewski MF, Khor YM, Jacob S, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Falk RH, Hyun H, Dorbala S. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT. J Nucl Med. 2019 09; 60(9):1234-1239.View Related Profiles.

Ruberg, Frederick
Sanchorawala, Vaishali

PMID: 30954943; PMCID: PMC6735282; DOI: 10.2967/jnumed.118.221770;

Sanchorawala V. Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details. Blood Adv. 2019 01 22; 3(2):216-218. PMID: 30670538; PMCID: PMC6341184; DOI: 10.1182/bloodadvances.2018021261;

Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplant. 2019 08; 54(8):1304-1309.View Related Profiles.

Sloan, J.
Quillen, Karen
Siddiqi, Omar
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 30664726

Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V. Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis. Biol Blood Marrow Transplant. 2019 05; 25(5):e169-e173.View Related Profiles.

Sloan, J.
Quillen, Karen
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 30639823

Dennis M, Maoz A, Hughes D, Sanchorawala V, Sloan JM, Sarosiek S. Bortezomib ocular toxicities: Outcomes with ketotifen. Am J Hematol. 2019 03; 94(3):E80-E82.View Related Profiles.

Sloan, J.
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 30575098

Lentzsch S, Lagos GG, Comenzo RL, Zonder JA, Pregja S, Osman K, Tsai WY, Landau H, Sanchorawala V. Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis. Amyloid. 2019; 26(sup1):113-114. PMID: 31343313

Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, Havasi A. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019 02; 95(2):405-411.View Related Profiles.

Havasi, Andrea
Doros, Gheorghe
Sloan, J.
Stern, Lauren
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 30580886

McCausland KL, Quock TP, Rizio AA, Bayliss MS, White MK, Guthrie SD, Sanchorawala V. Cardiac biomarkers and health-related quality of life in patients with light chain (AL) amyloidosis. Br J Haematol. 2019 06; 185(5):998-1001. PMID: 30467849

Merlini G, Dispenzieri A, Sanchorawala V, Schönland SO, Palladini G, Hawkins PN, Gertz MA. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Primers. 2018 10 25; 4(1):38. PMID: 30361521

Lilleness B, Ruberg FL, Mussinelli R, Doros G, Sanchorawala V. Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis. Blood. 2019 01 17; 133(3):215-223.View Related Profiles.

Lilleness, Brian
Ruberg, Frederick
Doros, Gheorghe
Sanchorawala, Vaishali

PMID: 30333122

Nguyen VP, Rosenberg A, Mendelson LM, Comenzo RL, Varga C, Sanchorawala V. Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis. Amyloid. 2018 Sep; 25(3):156-159.View Related Profiles.

Mendelson, Lisa
Sanchorawala, Vaishali
Nguyen, Vina

PMID: 30032640

Giadone RM, Rosarda JD, Akepati PR, Thomas AC, Boldbaatar B, James MF, Wilson AA, Sanchorawala V, Connors LH, Berk JL, Wiseman RL, Murphy GJ. A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics. Amyloid. 2018 Sep; 25(3):148-155.View Related Profiles.

Wilson, Andrew
Boldbaatar, Batbold
Murphy, George
Berk, John
Connors, Lawreen
Giadone, Richard
Sanchorawala, Vaishali

PMID: 30032658; PMCID: PMC6319917; DOI: 10.1080/13506129.2018.1489228;

Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Biol Blood Marrow Transplant. 2018 09; 24(9):1823-1827.View Related Profiles.

Sloan, J.
Quillen, Karen
Mendelson, Lisa
Sarosiek, Shayna
Sanchorawala, Vaishali
Nguyen, Vina

PMID: 29933072; PMCID: PMC7553205; DOI: 10.1016/j.bbmt.2018.06.018;

Sarosiek S, Quillen K, Sloan JM, Brauneis D, Sanchorawala V. Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation. Blood. 2018 08 16; 132(7):755-757.View Related Profiles.

Sloan, J.
Quillen, Karen
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 29903887

White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S, Sanchorawala V. High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone Marrow Transplant. 2018 12; 53(12):1593-1595.View Related Profiles.

Sloan, J.
Quillen, Karen
Phull, Pooja
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 29884854

Siddiqi OK, Sanchorawala V, Ruberg FL. Echocardiography and Survival in Light Chain Cardiac Amyloidosis: Back to Basics. Circ Cardiovasc Imaging. 2018 05; 11(5):e007826.View Related Profiles.

Ruberg, Frederick
Siddiqi, Omar
Sanchorawala, Vaishali

PMID: 29752394

Pudusseri A, Smith I, Sarnacki D, Brauneis D, Shelton A, Sanchorawala V, Sloan JM, Sarosiek S, Quillen K. Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients. Transfus Apher Sci. 2018 Jun; 57(3):411-415.View Related Profiles.

Sloan, J.
Quillen, Karen
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 29731423

Ding Y, Francis J, Gautam A, Pelletier L, Sanchorawala V, Quillen K. Durable renal response after combination of bortezomib, corticosteroids, rituximab, and plasmapheresis for late antibody-mediated renal transplant rejection?. Clin Nephrol. 2018 Apr; 89(4):252-259.View Related Profiles.

Gautam, Amitabh
Francis, Jean
Quillen, Karen
Sanchorawala, Vaishali

PMID: 29208204

Jhaveri T, Sarosiek S, Ruberg FL, Siddiqi O, Berk JL, Sanchorawala V. Once AL amyloidosis: not always AL amyloidosis. Amyloid. 2018 Jun; 25(2):139-140.View Related Profiles.

Ruberg, Frederick
Berk, John
Siddiqi, Omar
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 29516761

Havasi A, Doros G, Sanchorawala V. Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation. Am J Hematol. 2018 05; 93(5):E129-E132.View Related Profiles.

Havasi, Andrea
Doros, Gheorghe
Sanchorawala, Vaishali

PMID: 29430701; PMCID: PMC5893431; DOI: 10.1002/ajh.25066;

Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, Sarosiek S. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Amyloid. 2018 Mar; 25(1):62-67.View Related Profiles.

Ruberg, Frederick
Doros, Gheorghe
Berk, John
Connors, Lawreen
Phull, Pooja
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 29424556; PMCID: PMC6157907; DOI: 10.1080/13506129.2018.1436048;

Hari P, Lin HM, Asche CV, Ren J, Yong C, Luptakova K, Faller DV, Sanchorawala V. Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis. Amyloid. 2018 Mar; 25(1):1-7.View Related Profiles.

Faller, Douglas
Sanchorawala, Vaishali

PMID: 29303358

Lohrmann G, Arun M, Brauneis D, Quillen K, Sanchorawala V, Sarosiek S, Siddiqi O, Ruberg F, Gopal D. ABNORMAL LEFT ATRIAL MECHANICS PREDICT INCIDENT ATRIAL FIBRILLATION IN AL CARDIAC AMYLOIDOSIS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION. Journal of the American College of Cardiology. 2018; 71(11):A1517. View Publication

Nguyen VP, Brauneis D, Kaku M, Sloan JM, Sarosiek S, Quillen K, Shelton AC, Sanchorawala V. Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplant. 2018 03; 53(3):371-373.View Related Profiles.

Sloan, J.
Quillen, Karen
Kaku, Michelle
Sarosiek, Shayna
Sanchorawala, Vaishali
Nguyen, Vina

PMID: 29269794

White MK, McCausland KL, Sanchorawala V, Guthrie SD, Bayliss MS. Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples. Patient Relat Outcome Meas. 2017; 8:157-167. PMID: 29263707; PMCID: PMC5724409; DOI: 10.2147/PROM.S146849;

Batalini F, Econimo L, Quillen K, Sloan JM, Sarosiek S, Brauneis D, Havasi A, Stern L, Dember LM, Sanchorawala V. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease. Biol Blood Marrow Transplant. 2018 01; 24(1):127-132.View Related Profiles.

Havasi, Andrea
Sloan, J.
Quillen, Karen
Stern, Lauren
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 28865972

Salinaro F, Meier-Ewert HK, Miller EJ, Pandey S, Sanchorawala V, Berk JL, Seldin DC, Ruberg FL. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2017 Sep 01; 18(9):1057-1064.View Related Profiles.

Ruberg, Frederick
Meier-Ewert, Hans Kilian
Berk, John
Pandey, Shivda
Sanchorawala, Vaishali

PMID: 27965280; DOI: 10.1093/ehjci/jew298;

Sanchorawala V, McCausland KL, White MK, Bayliss MS, Guthrie SD, Lo S, Skinner M. A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time. Br J Haematol. 2017 Nov; 179(3):461-470.View Related Profiles.

Skinner, Martha
Sanchorawala, Vaishali

PMID: 28850697; PMCID: PMC5697591; DOI: 10.1111/bjh.14889;

Arun M, Brauneis D, Doros G, Shelton AC, Sloan JM, Quillen K, Ruberg FL, Sanchorawala V, Varga C. The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution. Bone Marrow Transplant. 2017 09; 52(9):1349-1351.View Related Profiles.

Ruberg, Frederick
Doros, Gheorghe
Sloan, J.
Quillen, Karen
Sanchorawala, Vaishali

PMID: 28737773

Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V. Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood. 2017 09 14; 130(11):1383-1386.View Related Profiles.

Doros, Gheorghe
Sloan, J.
Quillen, Karen
Browning, Sabrina
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 28698204

Sanchorawala V, Palladini G, Kukreti V, Zonder JA, Cohen AD, Seldin DC, Dispenzieri A, Jaccard A, Schönland SO, Berg D, Yang H, Gupta N, Hui AM, Comenzo RL, Merlini G. A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis. Blood. 2017 Aug 03; 130(5):597-605. PMID: 28550039; PMCID: PMC6911836; DOI: 10.1182/blood-2017-03-771220;

Govender P, Keyes CM, Hankinson EA, O'Hara CJ, Sanchorawala V, Berk JL. Transbronchial biopsies safely diagnose amyloid lung disease. Amyloid. 2017 Mar; 24(1):37-41.View Related Profiles.

O'Hara, Carl
Berk, John
Govender, Praveen
Sanchorawala, Vaishali

PMID: 28393574; PMCID: PMC6014610; DOI: 10.1080/13506129.2017.1301917;

Graham MS, Pudusseri A, Helgager J, Narendra DP, De Girolami U, Pinkus GS, Sanchorawala V, Miyawaki E. A Woman in Her 40s With Headache and New-Onset Seizures. JAMA Neurol. 2017 Apr 01; 74(4):476-480. PMID: 28241235; DOI: 10.1001/jamaneurol.2016.2961;

Pulido V, Doros G, Berk JL, Sanchorawala V. The six-minute walk test in patients with AL amyloidosis: a single centre case series. Br J Haematol. 2017 May; 177(3):388-394.View Related Profiles.

Doros, Gheorghe
Berk, John
Sanchorawala, Vaishali
Nguyen, Vina

PMID: 28340285; DOI: 10.1111/bjh.14586;

Liedtke M, Comenzo R, Landau H, Sanchorawala V, Weiss B, Zonder J, Walling J, Kinney G, Koller M, Schenk DB, Guthrie S, Liu E, Gertz M. NEOD001 DEMONSTRATES CARDIAC BIOMARKER RESPONSES IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS: RESULTS FROM THE PHASE 1/2 STUDY. Journal of the American College of Cardiology. 2017; 69(11):825. View Publication
Mccausland K, Guthrie S, Quock T, Yokota M, Bayliss M, White MK, Sanchorawala V. Improvements in Cardiac Biomarkers are Associated with Better Health-Related Quality of Life in Patients with Light Chain Amyloidosis. Journal of Cardiac Failure. 2017; 23(8):S114. View Publication
Gertz M, Comenzo RL, Landau H, Sanchorawala V, Weiss B, Zonder JA, Walling J, Kinney GG, Koller M, Schenk DB, Guthrie S, Liu E, Liedtke M. NEOD001 Demonstrates Organ Biomarker Responses in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From a Phase 1/2 Study. Clinical Lymphoma, Myeloma and Leukemia. 2017; 17(1):e22-e23. View Publication
Gertz M, Comenzo RL, Landau H, Sanchorawala V, Weiss B, Zonder JA, Walling J, Kinney GG, Koller M, Schenk DB, Guthrie S, Liu E, Liedtke M. Organ Biomarker Responses in Patients With Light Chain Amyloidosis Treated With NEOD001 Are Independent of Previous Hematologic Response. Clinical Lymphoma, Myeloma and Leukemia. 2017; 17(1):e97-e98. View Publication

Uwumugambi NA, Sanchorawala V, Shelton AC, Stern L, Gordon CE. Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis. Am J Kidney Dis. 2017 Feb; 69(2):317-319.View Related Profiles.

Gordon, Craig
Stern, Lauren
Sanchorawala, Vaishali

PMID: 27780577; DOI: 10.1053/j.ajkd.2016.07.037;

Prokaeva T, Spencer B, Sun F, O'Hara RM, Seldin DC, Connors LH, Sanchorawala V. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio. Amyloid. 2016 Dec; 23(4):214-220.View Related Profiles.

Sun, Fangui
Connors, Lawreen
Prokaeva, Tatiana
Sanchorawala, Vaishali

PMID: 27677679

Shu J, Lo S, Phillips M, Sun F, Seldin DC, Berenbaum I, Berk JL, Sanchorawala V. Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients. Amyloid. 2016 Sep; 23(3):188-193.View Related Profiles.

Sun, Fangui
Berenbaum, Isidore
Berk, John
Sanchorawala, Vaishali

PMID: 27460276

Merlini G, Lousada I, Ando Y, Dispenzieri A, Gertz MA, Grogan M, Maurer MS, Sanchorawala V, Wechalekar A, Palladini G, Comenzo RL. Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis. Leukemia. 2016 Oct; 30(10):1979-1986. PMID: 27416985; PMCID: PMC5056962; DOI: 10.1038/leu.2016.191;

Havasi A, Stern L, Lo S, Sun F, Sanchorawala V. Validation of new renal staging system in AL amyloidosis treated with high dose melphalan and stem cell transplantation. Am J Hematol. 2016 10; 91(10):E458-60.View Related Profiles.

Havasi, Andrea
Sun, Fangui
Stern, Lauren
Sanchorawala, Vaishali

PMID: 27356490; PMCID: PMC5031518; DOI: 10.1002/ajh.24464;

Sanchorawala V, Shelton AC, Lo S, Varga C, Sloan JM, Seldin DC. Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial. Blood. 2016 Aug 25; 128(8):1059-62.View Related Profiles.

Varga, Cindy
Sloan, J.
Sanchorawala, Vaishali

PMID: 27381904; DOI: 10.1182/blood-2016-04-710822;

Dittus C, Uwumugambi N, Sun F, Sloan JM, Sanchorawala V. The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016 Sep; 22(9):1729-1732.View Related Profiles.

Sun, Fangui
Sloan, J.
Sanchorawala, Vaishali

PMID: 27296954; DOI: 10.1016/j.bbmt.2016.05.027;

Arun M, Sloan SB, Shelton A, Sanchorawala V. Penile ulcers complicating systemic AL amyloidosis: a case report. Amyloid. 2016 Sep; 23(3):203-204. PMID: 27187183

Lee SY, Meehan RS, Seldin DC, Sloan JM, Quillen K, Shelton A, Brauneis D, Sanchorawala V. Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis. Bone Marrow Transplant. 2016 Oct; 51(10):1318-1322.View Related Profiles.

Sloan, J.
Quillen, Karen
Sanchorawala, Vaishali

PMID: 27183092; DOI: 10.1038/bmt.2016.132;

Sanchorawala V, Gale RP. David C Seldin, MD, PhD: scientist, clinician, teacher, gentleman, 1957-2015. Bone Marrow Transplant. 2016 Mar; 51(3):323. PMID: 26931484; DOI: 10.1038/bmt.2015.340;

Liedtke M, Comenzo RL, Landau H, Sanchorawala V, Weiss B, Zonder J, Walling J, Kinney GG, Koller M, Schenk DB, Guthrie S, Liu E, Gertz M. NEOD001 Demonstrates Cardiac Responses in Patients with Light Chain Amyloidosis and Persistent Organ Dysfunction in a Phase 1/2 Study Expansion. Journal of Cardiac Failure. 2016; 22(8):S64. View Publication

Sissoko M, Sanchorawala V, Seldin D, Sworder B, Angelino K, Broce M, Berk J, Sloan JM. Clinical presentation and treatment responses in IgM-related AL amyloidosis. Amyloid. 2015; 22(4):229-35.View Related Profiles.

Sloan, J.
Berk, John
Sanchorawala, Vaishali

PMID: 26488936; DOI: 10.3109/13506129.2015.1092433;

Bever KM, Masha LI, Sun F, Stern L, Havasi A, Berk JL, Sanchorawala V, Seldin DC, Sloan JM. Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis. Haematologica. 2016 Jan; 101(1):86-90.View Related Profiles.

Havasi, Andrea
Sun, Fangui
Sloan, J.
Berk, John
Stern, Lauren
Sanchorawala, Vaishali

PMID: 26452981; PMCID: PMC4697895; DOI: 10.3324/haematol.2015.133900;

Sanchorawala V, Sun F, Quillen K, Sloan JM, Berk JL, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience. Blood. 2015 Nov 12; 126(20):2345-7.View Related Profiles.

Sun, Fangui
Sloan, J.
Berk, John
Quillen, Karen
Sanchorawala, Vaishali

PMID: 26443620; DOI: 10.1182/blood-2015-08-662726;

Bosch N, Renteria AS, Quillen K, Brauneis D, Santilli J, Kim D, Sanchorawala V. Nonoperative Management of Spontaneous Splenic Rupture in a Patient with Light-Chain Amyloidosis: A Case Report. J Vasc Interv Radiol. 2015 Oct; 26(10):1578-80.View Related Profiles.

Quillen, Karen
Bosch, Nicholas
Sanchorawala, Vaishali

PMID: 26408221; DOI: 10.1016/j.jvir.2015.04.028;

Lee SY, Brauneis D, Stern L, Sanchorawala V. Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney. Hematol Oncol Stem Cell Ther. 2016 Jun; 9(2):86-8.View Related Profiles.

Stern, Lauren
Sanchorawala, Vaishali

PMID: 26303745; DOI: 10.1016/j.hemonc.2015.08.001;

Skinner M, Sanchorawala V. In memoriam David C. Seldin, MD, PhD. Amyloid. 2015; 22(3):145-6.View Related Profiles.

Skinner, Martha
Sanchorawala, Vaishali

PMID: 26300106; DOI: 10.3109/13506129.2015.1071103;

Skinner M, Sanchorawala V. In memoriam David C. Seldin, MD, PhD. Amyloid. 2015 Aug 07; 1-2.View Related Profiles.

Skinner, Martha
Sanchorawala, Vaishali

PMID: 26248523

Sarosiek S, Seldin DC, Connors LH, Spencer B, Murakami A, O'Hara C, Sanchorawala V. Vertebral compression fractures as the initial presentation of AL amyloidosis: case series and review of literature. Amyloid. 2015; 22(3):156-62.View Related Profiles.

Murakami, Akira
O'Hara, Carl
Connors, Lawreen
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 26104853; DOI: 10.3109/13506129.2015.1036983;

Sanchorawala V, Brauneis D, Shelton AC, Lo S, Sun F, Sloan JM, Quillen K, Seldin DC. Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial. Biol Blood Marrow Transplant. 2015 Aug; 21(8):1445-51.View Related Profiles.

Sun, Fangui
Sloan, J.
Quillen, Karen
Sanchorawala, Vaishali

PMID: 25858810; DOI: 10.1016/j.bbmt.2015.04.001;

Renteria AS, Sanchorawala V, Niehaus ED, Sun F, Semigran MJ, Seldin DC. Serum free light chain trends between orthotopic heart transplantation and auto-SCT in patients with AL amyloidosis. Bone Marrow Transplant. 2015 Jun; 50(6):868-9.View Related Profiles.

Seldin, David
Sun, Fangui
Sanchorawala, Vaishali

PMID: 25751645; DOI: 10.1038/bmt.2015.9;

Sanchorawala V. High dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis. Hematol Oncol Clin North Am. 2014 Dec; 28(6):1131-44. PMID: 25459183; DOI: 10.1016/j.hoc.2014.08.013;

Fu J, Seldin DC, Berk JL, Sun F, O'Hara C, Cui H, Sanchorawala V. Lymphadenopathy as a manifestation of amyloidosis: a case series. Amyloid. 2014 Dec; 21(4):256-60.View Related Profiles.

O'Hara, Carl
Seldin, David
Sun, Fangui
Berk, John
Sanchorawala, Vaishali

PMID: 25208081; DOI: 10.3109/13506129.2014.958610;

Reece DE, Hegenbart U, Sanchorawala V, Merlini G, Palladini G, Bladé J, Fermand JP, Hassoun H, Heffner L, Kukreti V, Vescio RA, Pei L, Enny C, Esseltine DL, van de Velde H, Cakana A, Comenzo RL. Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis. Blood. 2014 Oct 16; 124(16):2498-506. PMID: 25202139; PMCID: PMC4199951; DOI: 10.1182/blood-2014-04-568329;

Freeman B, Brauneis D, Seldin DC, Quillen K, Sloan JM, Renteria AS, Shelton AC, Teschner T, Finn KT, Sanchorawala V. Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis. Bone Marrow Transplant. 2014 Oct; 49(10):1345-6.View Related Profiles.

Seldin, David
Sloan, J.
Quillen, Karen
Sanchorawala, Vaishali

PMID: 24955784; DOI: 10.1038/bmt.2014.132;

Lee SY, Sanchorawala V, Seldin DC, Mark Sloan J, Andrea N, Quillen K. Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series. Amyloid. 2014 Sep; 21(3):149-53.View Related Profiles.

Seldin, David
Sloan, J.
Quillen, Karen
Sanchorawala, Vaishali

PMID: 24779777; DOI: 10.3109/13506129.2014.900486;

Lichtman EI, Seldin DC, Shelton A, Sanchorawala V. Single agent lenalidomide three times a week induces hematologic responses in AL amyloidosis patients on dialysis. Am J Hematol. 2014 Jul; 89(7):706-8.View Related Profiles.

Seldin, David
Sanchorawala, Vaishali

PMID: 24668858; DOI: 10.1002/ajh.23722;

Mahmood S, Palladini G, Sanchorawala V, Wechalekar A. Update on treatment of light chain amyloidosis. Haematologica. 2014 Feb; 99(2):209-21. PMID: 24497558; PMCID: PMC3912950; DOI: 10.3324/haematol.2013.087619;

von Keudell G, Sanchorawala V, O'Hara C, C Seldin D, Sloan JM. Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis. Amyloid. 2014 Jun; 21(2):124-7.View Related Profiles.

O'Hara, Carl
Sloan, J.
Sanchorawala, Vaishali

PMID: 24471777; DOI: 10.3109/13506129.2013.854205;

Zonder J, Houde C, Tuchman S, Kukreti V, Sanchorawala V, Pregja S, Reichel KA, Burt SM, Neveux C, Matous J. Blood. A Phase I Trial of Pomalidomide, Bortezomib (Velcade), and Dexamethasone (PVD) As Initial Treatment of AL Amyloidosis and Light Chain Deposition Disease. 2014.
Finn KT, Fennessey S, Shelton A, Brauneis D, Teschner T, Quillen K, Sloan JM, Renteria AS, Seldin DC, Sanchorawala V. A Multidisciplinary Team Approach for Diagnosis and Treatment of Patients with AL Amyloidosis. Biology of Blood and Marrow Transplantation. 2014; 20(2):S160. View Publication

Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V. Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant. 2014 Mar; 49(3):434-9.View Related Profiles.

Seldin, David
Ruberg, Frederick
Doros, Gheorghe
Meier-Ewert, Hans Kilian
Sloan, J.
Berk, John
Quillen, Karen
Sanchorawala, Vaishali

PMID: 24317129; DOI: 10.1038/bmt.2013.192;

Sanchorawala V, Hoering A, Seldin DC, Finn KT, Fennessey SA, Sexton R, Mattar B, Safah HF, Holmberg LA, Dean RM, Orlowski RZ, Barlogie B. Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115. Bone Marrow Transplant. 2013 Nov; 48(12):1537-42.View Related Profiles.

Seldin, David
Sanchorawala, Vaishali

PMID: 23852321; PMCID: PMC3855173; DOI: 10.1038/bmt.2013.98;

Girnius S, Seldin DC, Cibeira MT, Sanchorawala V. New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation. J Clin Oncol. 2013 Jul 20; 31(21):2749-50.View Related Profiles.

Seldin, David
Sanchorawala, Vaishali

PMID: 23775968; DOI: 10.1200/JCO.2013.48.7736;

Sanchorawala V, Shelton AC, Zeldis JB, Seldin DC. Risk of second primary malignancy in patients with AL amyloidosis treated with lenalidomide. Am J Hematol. 2013 Aug; 88(8):719.View Related Profiles.

Seldin, David
Sanchorawala, Vaishali

PMID: 23650113; DOI: 10.1002/ajh.23470;

Sarosiek S, Seldin DC, Berk JL, Sanchorawala V. A solitary mediastinal mass due to localized AL amyloidosis: case report and review of the literature. Amyloid. 2013 Jun; 20(2):127-30.View Related Profiles.

Seldin, David
Berk, John
Sarosiek, Shayna
Sanchorawala, Vaishali

PMID: 23461593; DOI: 10.3109/13506129.2013.775644;

Taimur S, Nader C, Lloyd-Travaglini C, Seldin DC, Sanchorawala V. Microbiologically documented infections in patients undergoing high-dose melphalan and autologous stem cell transplantation for the treatment of light chain amyloidosis. Transpl Infect Dis. 2013 Apr; 15(2):187-94.View Related Profiles.

Nader, Claudia
Seldin, David
Sanchorawala, Vaishali

PMID: 23279695; DOI: 10.1111/tid.12037;

Tsai SB, Seldin DC, Quillen K, Berk JL, Ruberg FL, Meier-Ewert H, Sloan JM, Doros G, Finn KT, Skinner M, Sanchorawala V. High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center. Blood. 2012 Nov 22; 120(22):4445-6.View Related Profiles.

Seldin, David
Ruberg, Frederick
Doros, Gheorghe
Meier-Ewert, Hans Kilian
Sloan, J.
Berk, John
Quillen, Karen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 23175664; DOI: 10.1182/blood-2012-09-457341;

Sanchorawala V, Patel JM, Sloan JM, Shelton AC, Zeldis JB, Seldin DC. Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial. Haematologica. 2013 May; 98(5):789-92.View Related Profiles.

Seldin, David
Sloan, J.
Sanchorawala, Vaishali

PMID: 23144200; PMCID: PMC3640126; DOI: 10.3324/haematol.2012.075192;

Cowan AJ, Seldin DC, Skinner M, Quillen K, Doros G, Tan J, O'Hara C, Finn KT, Sanchorawala V. Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftment. Biol Blood Marrow Transplant. 2012 Dec; 18(12):1935-8.View Related Profiles.

O'Hara, Carl
Seldin, David
Doros, Gheorghe
Tan, Josenia
Quillen, Karen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 22842332; PMCID: PMC4161277; DOI: 10.1016/j.bbmt.2012.07.016;

Cowan AJ, Skinner M, Seldin DC, Berk JL, Lichtenstein DR, O'Hara CJ, Doros G, Sanchorawala V. Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. Haematologica. 2013 Jan; 98(1):141-6.View Related Profiles.

O'Hara, Carl
Seldin, David
Lichtenstein, David
Doros, Gheorghe
Berk, John
Skinner, Martha
Sanchorawala, Vaishali

PMID: 22733017; PMCID: PMC3533676; DOI: 10.3324/haematol.2012.068155;

Freeman B, Sloan JM, Seldin DC, Cowan AJ, Ruberg FL, Sanchorawala V. Multiple arterial and venous thromboembolic complications in AL amyloidosis and cardiac involvement: a case report and literature review. Amyloid. 2012 Sep; 19(3):156-60.View Related Profiles.

Seldin, David
Ruberg, Frederick
Sloan, J.
Sanchorawala, Vaishali

PMID: 22680044; DOI: 10.3109/13506129.2012.694825;

Comenzo RL, Reece D, Palladini G, Seldin D, Sanchorawala V, Landau H, Falk R, Wells K, Solomon A, Wechalekar A, Zonder J, Dispenzieri A, Gertz M, Streicher H, Skinner M, Kyle RA, Merlini G. Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia. 2012 Nov; 26(11):2317-25.View Related Profiles.

Seldin, David
Sanchorawala, Vaishali

PMID: 22475872; DOI: 10.1038/leu.2012.100;

Seldin DC, Sanchorawala V. Amyloidomics comes of age. Blood. 2012 Feb 23; 119(8):1795-6.View Related Profiles.

Seldin, David
Sanchorawala, Vaishali

PMID: 22361969; DOI: 10.1182/blood-2011-10-381178;

Sanchorawala V, Seldin DC. AL amyloidosis: who, what, when, why, and where. Oncology (Williston Park). 2012 Feb; 26(2):164, 166, 169.View Related Profiles.

Seldin, David
Sanchorawala, Vaishali

PMID: 22489350

Sanchorawala V. Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis. Am J Blood Res. 2012; 2(1):9-17. PMID: 22432083; PMCID: PMC3301435

Meier-Ewert HK, Sanchorawala V, Berk JL, Ruberg FL. Cardiac amyloidosis: evolving approach to diagnosis and management. Curr Treat Options Cardiovasc Med. 2011 Dec; 13(6):528-42.View Related Profiles.

Ruberg, Frederick
Meier-Ewert, Hans Kilian
Berk, John
Sanchorawala, Vaishali

PMID: 21989745; DOI: 10.1007/s11936-011-0147-4;

Sanchorawala V, Quillen K, Sloan JM, Andrea NT, Seldin DC. Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study. Haematologica. 2011 Dec; 96(12):1890-2.View Related Profiles.

Seldin, David
Sloan, J.
Quillen, Karen
Sanchorawala, Vaishali

PMID: 21859734; PMCID: PMC3232278; DOI: 10.3324/haematol.2011.049858;

Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011 Oct 20; 118(16):4346-52.View Related Profiles.

Seldin, David
Ruberg, Frederick
Doros, Gheorghe
Meier-Ewert, Hans Kilian
Sloan, J.
Berk, John
Quillen, Karen
Dember, Laura
Skinner, Martha
Sanchorawala, Vaishali

PMID: 21828140; PMCID: PMC3204906; DOI: 10.1182/blood-2011-01-330738;

Dubrey SW, Reece DE, Sanchorawala V, Hegenbart U, Merlini G, Palladini G, Fermand JP, Vescio RA, Bladé J, Heffner LT, Hassoun H, Liu X, Enny C, Ramaswami P, Elsayed Y, Van De Velde H, Mortimer S, Cakana A, Comenzo RL. Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects. QJM. 2011 Nov; 104(11):957-70. PMID: 21752867; DOI: 10.1093/qjmed/hcr105;

Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid. 2011 Jun; 18 Suppl 1:127-9.View Related Profiles.

Lerner, Adam
O'Hara, Carl
Libbey, Caryn
Seldin, David
Sam, Flora
Ruberg, Frederick
Doros, Gheorghe
Meier-Ewert, Hans Kilian
Berenbaum, Isidore
Sloan, J.
Wiesman, Janice
Berk, John
Quillen, Karen
Dember, Laura
Connors, Lawreen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 21838459; PMCID: PMC5601311; DOI: 10.3109/13506129.2011.574354047;

Meier-Ewert HK, Sanchorawala V, Berk J, Finn KT, Skinner M, Seldin DC, Ruberg FL. Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis. Amyloid. 2011 Jun; 18 Suppl 1:130-1.View Related Profiles.

Seldin, David
Ruberg, Frederick
Meier-Ewert, Hans Kilian
Berk, John
Skinner, Martha
Sanchorawala, Vaishali

PMID: 21838460; DOI: 10.3109/13506129.2011.574354048;

Seldin DC, Berk JL, Sam F, Sanchorawala V. Amyloidotic cardiomyopathy: multidisciplinary approach to diagnosis and treatment. Heart Fail Clin. 2011 Jul; 7(3):385-93.View Related Profiles.

Seldin, David
Sam, Flora
Berk, John
Sanchorawala, Vaishali

PMID: 21749890; PMCID: PMC3135875; DOI: 10.1016/j.hfc.2011.03.009;

Reece DE, Hegenbart U, Sanchorawala V, Merlini G, Palladini G, Bladé J, Fermand JP, Hassoun H, Heffner L, Vescio RA, Liu K, Enny C, Esseltine DL, van de Velde H, Cakana A, Comenzo RL. Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study. Blood. 2011 Jul 28; 118(4):865-73. PMID: 21562045; DOI: 10.1182/blood-2011-02-334227;

Tsai SB, Seldin DC, Wu H, O'Hara C, Ruberg FL, Sanchorawala V. Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review. Amyloid. 2011 Sep; 18(3):160-4.View Related Profiles.

O'Hara, Carl
Seldin, David
Ruberg, Frederick
Sanchorawala, Vaishali

PMID: 21504342; DOI: 10.3109/13506129.2011.571319;

Charlot M, Seldin DC, O'hara C, Skinner M, Sanchorawala V. Localized amyloidosis of the breast: a case series. Amyloid. 2011 Jun; 18(2):72-5.View Related Profiles.

O'Hara, Carl
Seldin, David
Charlot, Marjory
Skinner, Martha
Sanchorawala, Vaishali

PMID: 21501022; DOI: 10.3109/13506129.2011.570817;

Cowan AJ, Skinner M, Berk JL, Sloan JM, O'hara C, Seldin DC, Sanchorawala V. Macroglossia - not always AL amyloidosis. Amyloid. 2011 Jun; 18(2):83-6.View Related Profiles.

O'Hara, Carl
Seldin, David
Sloan, J.
Berk, John
Skinner, Martha
Sanchorawala, Vaishali

PMID: 21401321; DOI: 10.3109/13506129.2011.560217;

Seldin DC, Berk JL, Sam F, Sanchorawala V. Amyloidotic cardiomyopathy: Multidisciplinary approach to diagnosis and treatment. In: Heart Failure Clinics, Ed by Daniel J. Lenihan and Douglas B. Sawyer. 2011.

Tapan U, Seldin DC, Finn KT, Fennessey S, Shelton A, Zeldis JB, Sanchorawala V. Increases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis. Blood. 2010 Dec 2; 116(23):5071-2.View Related Profiles.

Seldin, David
Tapan, Umit
Sanchorawala, Vaishali

PMID: 21127185; DOI: 10.1182/blood-2010-09-305136;

Sanchorawala V, Seldin DC, Berk JL, Sloan JM, Doros G, Skinner M. Oral cyclic melphalan and dexamethasone for patients with AL amyloidosis. Clin Lymphoma Myeloma Leuk. 2010 Dec; 10(6):469-72.View Related Profiles.

Seldin, David
Doros, Gheorghe
Sloan, J.
Berk, John
Skinner, Martha
Sanchorawala, Vaishali

PMID: 21156464; DOI: 10.3816/CLML.2010.n.081;

Dey BR, Chung SS, Spitzer TR, Zheng H, Macgillivray TE, Seldin DC, McAfee S, Ballen K, Attar E, Wang T, Shin J, Newton-Cheh C, Moore S, Sanchorawala V, Skinner M, Madsen JC, Semigran MJ. Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure. Transplantation. 2010 Oct 27; 90(8):905-11.View Related Profiles.

Seldin, David
Skinner, Martha
Sanchorawala, Vaishali

PMID: 20733534; PMCID: PMC2964067; DOI: 10.1097/TP.0b013e3181f10edb;

Quillen K, Seldin DC, Finn KT, Sanchorawala V. A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis. Bone Marrow Transplant. 2011 Jul; 46(7):976-80.View Related Profiles.

Seldin, David
Quillen, Karen
Sanchorawala, Vaishali

PMID: 20956955; DOI: 10.1038/bmt.2010.239;

Sanchorawala V, Finn KT, Fennessey S, Shelton A, Doros G, Zeldis JB, Seldin DC. Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis. Blood. 2010 Sep 16; 116(11):1990-1.View Related Profiles.

Seldin, David
Doros, Gheorghe
Sanchorawala, Vaishali

PMID: 20847211; DOI: 10.1182/blood-2010-07-295485;

Specter R, Sanchorawala V, Seldin DC, Shelton A, Fennessey S, Finn KT, Zeldis JB, Dember LM. Kidney dysfunction during lenalidomide treatment for AL amyloidosis. Nephrol Dial Transplant. 2011 Mar; 26(3):881-6.View Related Profiles.

Seldin, David
Dember, Laura
Sanchorawala, Vaishali

PMID: 20693160; PMCID: PMC3108346; DOI: 10.1093/ndt/gfq482;

Girnius S, Seldin DC, Quillen K, Dember LM, Segal A, Sanchorawala V. Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation. Bone Marrow Transplant. 2011 Jan; 46(1):161-2.View Related Profiles.

Seldin, David
Quillen, Karen
Dember, Laura
Sanchorawala, Vaishali

PMID: 20383204; DOI: 10.1038/bmt.2010.82;

Sanchorawala V, Jacobson DR, Seldin DC, Buxbaum JN. The Amyloidoses. In Williams Textbook of Hematology, Ed by Thomas Kipps and Marshall Lichtmann. 2010.
Sanchorawala V, Bolejack V, Crowley J, Hoering A, Finn KT, Fennessey S, Seldin DC, Barlogie B. Modified high-dose melphalan and autologous stem cell transplantation (mHDM/SCT) in the treatment of AL amyloidosis (AL) and/or high-risk myeloma (hM): Analysis of a Southwest Oncology Group trial. Journal of Clinical Oncology. 2010; 28(15 suppl):8022. View Publication
Sanchorawala V, Bolejack V, Crowley J, Hoering A, Finn KT, Fennessey S, Seldin DC, Barlogie B. Amyloid. Modified high dose melphalan and autologous stem cell transplantation (HDM/SCT) in the treatment of AL amyloidosis: analysis of a Southwest Oncology Group trial. 2010.
Sanchorawala V, Yanarella L, Quillen K, Sloan JK, Andrea NT, Finn KT, Seldin DC. Bortezomib And High Dose Melphalan Followed By Autologous Stem Cell Transplantation (B-HDM/SCT) For The Treatment Of Al Amyloidosis: Results Of A Feasibility Study. Biology of Blood and Marrow Transplantation. 2010; 16(2). View Publication
Ruberg FL, Sanchorawala V, Berk J, Finn KT, Skinner M, Seldin DC, Meier-Ewert H. REDUCTION IN VENTRICULAR WALL THICKNESS FOLLOWING HIGH-DOSE CHEMOTHERAPY AND STEM-CELL TRANSPLANTATION FOR AL CARDIAC AMYLOIDOSIS. Journal of the American College of Cardiology. 2010; 55(10). View Publication

Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V. Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis. Ann Hematol. 2010 Jun; 89(6):579-84.View Related Profiles.

Seldin, David
Doros, Gheorghe
Quillen, Karen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 20012043; DOI: 10.1007/s00277-009-0874-8;

Reece DE, Sanchorawala V, Hegenbart U, Merlini G, Palladini G, Fermand JP, Vescio RA, Liu X, Elsayed YA, Cakana A, Comenzo RL. Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study. Blood. 2009 Aug 20; 114(8):1489-97. PMID: 19498019; DOI: 10.1182/blood-2009-02-203398;

Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V. Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease. Haematologica. 2009 Jul; 94(7):1029-32.View Related Profiles.

Seldin, David
Doros, Gheorghe
Quillen, Karen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 19454500; PMCID: PMC2704317; DOI: 10.3324/haematol.2008.001925;

Rosenzweig M, Seldin DC, Remick DG, Skinner M, Quillen K, Oran B, Finn KT, Sanchorawala V. Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction. Bone Marrow Transplant. 2010 Jan; 45(1):21-4.View Related Profiles.

Remick, Daniel
Seldin, David
Quillen, Karen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 19421171; PMCID: PMC3672063; DOI: 10.1038/bmt.2009.94;

Finn KT, Fennessey S, Yanarella L, Antonelli C, Shelton A, Daniel S, Skinner M, Seldin D, Quillen K, Sanchorawala V. Clinical Pathways and Standard Operating Procedures: Essential Tools for Outpatient Stem Cell Transplant Programs Treating Patients With AL Amyloidosis. Biology of Blood and Marrow Transplantation. 2009; 15(2):40-41. View Publication

Tam M, Seldin DC, Forbes BM, Connors LH, Skinner M, Oran B, Quillen K, Sanchorawala V. Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review. Amyloid. 2009; 16(2):103-7.View Related Profiles.

Seldin, David
Quillen, Karen
Connors, Lawreen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 20536404; PMCID: PMC2911629; DOI: 10.1080/13506120902879574;

Sanchorawala V, Skinner M, Finn KT, Quillen K, Seldin DC. Treatment-Related Mortality in Patients with AL Amyloidosis Undergoing High-Dose Melphalan and Stem Cell Transplantation: Trend Over The Past 14 Years at a Single Institution. Biology of Blood and Marrow Transplantation. 2009; 15(2):11. View Publication

Batts ED, Sanchorawala V, Hegerfeldt Y, Lazarus HM. Azotemia associated with use of lenalidomide in plasma cell dyscrasias. Leuk Lymphoma. 2008 Jun; 49(6):1108-15. PMID: 18452093; DOI: 10.1080/10428190802023707;

Sanchorawala V. AL (Immunoglobulin Light-Chain) Amyloidosis. In Myeloma Therapy: Pursuing the Plasma Cell, Ed by Sagar Lonial. Springer. New York. 2008.

Sanchorawala V, Seldin DC. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis. Amyloid. 2007 Dec; 14(4):261-9.View Related Profiles.

Seldin, David
Sanchorawala, Vaishali

PMID: 17968685

Sanchorawala V, Skinner M, Quillen K, Finn KT, Doros G, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation. Blood. 2007 Nov 15; 110(10):3561-3.View Related Profiles.

Seldin, David
Doros, Gheorghe
Quillen, Karen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 17673601; PMCID: PMC2077307; DOI: 10.1182/blood-2007-07-099481;

Sanchorawala V, Wright DG, Quillen K, Finn KT, Dember LM, Berk JL, Doros G, Fisher C, Skinner M, Seldin DC. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis. Bone Marrow Transplant. 2007 Sep; 40(6):557-62.View Related Profiles.

Seldin, David
Doros, Gheorghe
Berk, John
Quillen, Karen
Dember, Laura
Skinner, Martha
Sanchorawala, Vaishali

PMID: 17589534

Salant DJ, Sanchorawala V, D'Agati VD. A case of atypical light chain deposition disease--diagnosis and treatment. Clin J Am Soc Nephrol. 2007 Jul; 2(4):858-67.View Related Profiles.

Salant, David
Sanchorawala, Vaishali

PMID: 17699503

Kos CA, Ward JE, Malek K, Sanchorawala V, Wright DG, O'Hara C, Connors L, Skinner M, Seldin DC. Association of acquired von Willebrand syndrome with AL amyloidosis. Am J Hematol. 2007 May; 82(5):363-7.View Related Profiles.

O'Hara, Carl
Seldin, David
Ward, Jennifer
Connors, Lawreen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 17205535

Seldin DC, Rosenzweig M, Finn KT, Fennessey S, Shelton A, Zeldis JB, Skinner M, Sanchorawala V. Blood. Durable responses to lenalidomide (Revlimid (R)) in patients with AL amyloidosis: Follow up of a phase II trial. 2007.

Seldin DC, Sanchorawala V. Adapting to AL amyloidosis. Haematologica. 2006 Dec; 91(12):1591-5.View Related Profiles.

Seldin, David
Sanchorawala, Vaishali

PMID: 17145594

Sanchorawala V. Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol. 2006 Nov; 1(6):1331-41. PMID: 17699366

Sanchorawala V, Wright DG, Rosenzweig M, Finn KT, Fennessey S, Zeldis JB, Skinner M, Seldin DC. Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial. Blood. 2007 Jan 15; 109(2):492-6.View Related Profiles.

Seldin, David
Skinner, Martha
Sanchorawala, Vaishali

PMID: 16960148

Sanchorawala V, Blanchard E, Seldin DC, O'Hara C, Skinner M, Wright DG. AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes. Am J Hematol. 2006 Sep; 81(9):692-5.View Related Profiles.

O'Hara, Carl
Seldin, David
Skinner, Martha
Sanchorawala, Vaishali

PMID: 16795060

Seldin DC, Anderson JJ, Skinner M, Malek K, Wright DG, Quillen K, Finn K, Oran B, Sanchorawala V. Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65. Blood. 2006 Dec 1; 108(12):3945-7.View Related Profiles.

Seldin, David
Anderson, Jennifer
Quillen, Karen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 16926284; PMCID: PMC1895463; DOI: 10.1182/blood-2006-06-029728;

Weichman K, Dember LM, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, Sanchorawala V. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant. 2006 Sep; 38(5):339-43.View Related Profiles.

Seldin, David
Quillen, Karen
Dember, Laura
Skinner, Martha
Prokaeva, Tatiana
Sanchorawala, Vaishali

PMID: 16862166

Sanchorawala V, Wright DG, Rosenzweig M, Finn KT, Skinner M, Seldin DC. A phase II trial of lenalidomide for patients with AL amyloidosis. J Clin Oncol. 2006 Jun 20; 24(18_suppl):7524.View Related Profiles.

Skinner, Martha
Sanchorawala, Vaishali

PMID: 27955467

Rosenzweig M, Sawyer D, Ruberg F, Sanchorawala V, Seldin D, Vita J, Skinner M. Amyloid. A Trial of Antioxidants to Improve Cardiac Function in Patients with Al Amyloidosis and Cardiac Involvement. 2006. View Publication
Sanchorawala V, Wright DG, Quillen K, Finn KT, Dember LM, Berk J, Skinner M, Seldin DC. Amyloid. Treatment of AL amyloidosis with tandem cycles of high dose melphalan and autologous stem cell transplantation: Final analysis of a prospective trial. 2006. View Publication
Finn K, Fennessey S, Seldin D, Sanchorawala V, Shelton A, Allten S, Antonelli C. Skin reactions associated with oral Revlimid (lenalidomide) in al amyloidosis (ALA); Patient teaching encouraging prompt reporting, and clinical assessment. Oncology nursing forum. 2006; 33(2):395.
Baribeault D, Shah B, Finn KT, Seldin DC, Quillen K, Sanchorawala V. A retrospective analysis of the impact of erythropoeitic growth factor utilization on transfusion requirements in patients with AL amyloidosis undergoing autologous SCT. Biology of Blood and Marrow Transplantation. 2006; 12(2):138. View Publication

Akar H, Seldin DC, Magnani B, O'Hara C, Berk JL, Schoonmaker C, Cabral H, Dember LM, Sanchorawala V, Connors LH, Falk RH, Skinner M. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid. 2005 Dec; 12(4):210-5.View Related Profiles.

O'Hara, Carl
Seldin, David
Cabral, Howard
Berk, John
Dember, Laura
Connors, Lawreen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 16399645

Sanchorawala V, Seldin DC, Magnani B, Skinner M, Wright DG. Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis. Bone Marrow Transplant. 2005 Oct; 36(7):597-600.View Related Profiles.

Seldin, David
Skinner, Martha
Sanchorawala, Vaishali

PMID: 16044137

Berk JL, Wiesman JF, Skinner M, Sanchorawala V. Diaphragm paralysis in primary systemic amyloidosis. Amyloid. 2005 Sep; 12(3):193-6.View Related Profiles.

Wiesman, Janice
Berk, John
Skinner, Martha
Sanchorawala, Vaishali

PMID: 16194876

Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005 Aug; 79(4):319-28. PMID: 16044444

Oran B, Malek K, Sanchorawala V, Wright DG, Quillen K, Finn KT, La Valley M, Skinner M, Seldin DC. Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplant. 2005 Mar; 35(6):567-75.View Related Profiles.

Seldin, David
Quillen, Karen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 15665842

Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Berk JL, Dember LM, Falk RH, Skinner M. Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood. 2004 Sep 15; 104(6):1888-93.View Related Profiles.

Seldin, David
Anderson, Jennifer
Berk, John
Quillen, Karen
Dember, Laura
Skinner, Martha
Sanchorawala, Vaishali

PMID: 15155460

Sanchorawala V, Wright DG, Seldin DC, Falk RH, Finn KT, Dember LM, Berk JL, Quillen K, Anderson JJ, Comenzo RL, Skinner M. High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplant. 2004 Feb; 33(4):381-8.View Related Profiles.

Seldin, David
Anderson, Jennifer
Berk, John
Quillen, Karen
Dember, Laura
Skinner, Martha
Sanchorawala, Vaishali

PMID: 14676787

Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004 Jan 20; 140(2):85-93.View Related Profiles.

O'Hara, Carl
Libbey, Caryn
Seldin, David
Wiesman, Janice
Anderson, Jennifer
Berk, John
Quillen, Karen
Dember, Laura
Skinner, Martha
Sanchorawala, Vaishali

PMID: 14734330

Gertz M, Comenzo R, Falk RH, Fermand JP, Hazenberg BPC, Hawkins PN, Merlini G, Philippe M, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Amyloid and Amyloidosis. Definition of Organ Involvement and Treatment Response in Primary Systemic Amyloidosis (Al). 2004; 151-153. View Publication
Finn KT, Sanchorawala V, Kunz R, Seldin D, Wilkes G, Oran B. Cryotherapy (ice chips) is effective in preventing melphalan-induced oral mucositis (OM) in patients with AL amyloidosis. Biology of Blood and Marrow Transplantation. 2004; 10(1):86. View Publication
Baribeault D, Finn KT, Kunz R, Seldin DC, Sanchorawala V. A retrospective comparison of the impact of darbepoetin or epoetin usage on red cell transfusions transfusions in autologous stem cell transplantation (SCT) for light-chain related amyloidosis. Biology of Blood and Marrow Transplantation. 2004; 10(1):92. View Publication

Oran B, Wright DG, Seldin DC, McAneny D, Skinner M, Sanchorawala V. Spontaneous rupture of the spleen in AL amyloidosis. Am J Hematol. 2003 Oct; 74(2):131-5.View Related Profiles.

McAneny, David
Seldin, David
Skinner, Martha
Sanchorawala, Vaishali

PMID: 14508801

Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, Falk RH. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest. 2003 Sep; 124(3):969-77.View Related Profiles.

Seldin, David
Berk, John
Dember, Laura
Sanchorawala, Vaishali

PMID: 12970025

Fadia A, Casserly LF, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM. Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int. 2003 May; 63(5):1868-73.View Related Profiles.

Seldin, David
Dember, Laura
Skinner, Martha
Sanchorawala, Vaishali

PMID: 12675865

Casserly LF, Fadia A, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM. High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease. Kidney Int. 2003 Mar; 63(3):1051-7.View Related Profiles.

Seldin, David
Dember, Laura
Skinner, Martha
Sanchorawala, Vaishali

PMID: 12631087

Seldin DC, Choufani EB, Dember LM, Wiesman JF, Berk JL, Falk RH, O'Hara C, Fennessey S, Finn KT, Wright DG, Skinner M, Sanchorawala V. Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis. Clin Lymphoma. 2003 Mar; 3(4):241-6.View Related Profiles.

O'Hara, Carl
Seldin, David
Wiesman, Janice
Berk, John
Dember, Laura
Skinner, Martha
Sanchorawala, Vaishali

PMID: 12672274

Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M. Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol. 2002 Jun; 117(4):886-9.View Related Profiles.

Seldin, David
Berk, John
Dember, Laura
Skinner, Martha
Sanchorawala, Vaishali

PMID: 12060126

Akpek G, Lenz G, Lee SM, Sanchorawala V, Wright DG, Colarusso T, Waraska K, Lerner A, Vosburgh E, Skinner M, Comenzo RL. Immunologic recovery after autologous blood stem cell transplantation in patients with AL-amyloidosis. Bone Marrow Transplant. 2001 Dec; 28(12):1105-9.View Related Profiles.

Lerner, Adam
Skinner, Martha
Sanchorawala, Vaishali

PMID: 11803350

Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant. 2001 Oct; 28(7):637-42.View Related Profiles.

Seldin, David
Berk, John
Quillen, Karen
Dember, Laura
Skinner, Martha
Sanchorawala, Vaishali

PMID: 11704785

Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med. 2001 May 1; 134(9 Pt 1):746-53.View Related Profiles.

Seldin, David
Berk, John
Dember, Laura
Skinner, Martha
LaValley, Michael
Sanchorawala, Vaishali

PMID: 11329232

Choufani EB, Sanchorawala V, Ernst T, Quillen K, Skinner M, Wright DG, Seldin DC. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood. 2001 Mar 15; 97(6):1885-7.View Related Profiles.

Seldin, David
Quillen, Karen
Skinner, Martha
Sanchorawala, Vaishali

PMID: 11238135

Comenzo RL, Sanchorawala V, Fisher C, Akpek G, Farhat M, Cerda S, Berk JL, Dember LM, Falk R, Finn K, Skinner M, Vosburgh E. Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis. Br J Haematol. 1999 Mar; 104(3):553-9.View Related Profiles.

Berk, John
Dember, Laura
Skinner, Martha
Cerda, Sandra
Sanchorawala, Vaishali

PMID: 10086794

Comenzo RL, Vosburgh E, Falk RH, Sanchorawala V, Reisinger J, Dubrey S, Dember LM, Berk JL, Akpek G, LaValley M, O'hara C, Arkin CF, Wright DG, Skinner M. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood. 1998 May 15; 91(10):3662-70.View Related Profiles.

O'Hara, Carl
Berk, John
Dember, Laura
Skinner, Martha
LaValley, Michael
Sanchorawala, Vaishali

PMID: 9573002

Mendes LA, Reisinger J, Dubrey S, Comenzo R, Vosburgh E, Sanchorawala V, Lavalley MP, Skinner M, Falk RH. Echocardiographic identification of cardiac amyloidosis patients capable of undergoing intensive treatment with intravenous melphalan therapy. Journal of the American College of Cardiology. 1998; 31:109. View Publication

Fan-Harvard P, Sanchorawala V, Oh J, Moser EM, Smith SP. Concurrent use of foscarnet and ciprofloxacin may increase the propensity for seizures. Ann Pharmacother. 1994 Jul-Aug; 28(7-8):869-72. PMID: 7949502

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 217 publications over 25 distinct years, with a maximum of 19 publications in 2020

Bar chart showing 217 publications over 25 distinct years, with a maximum of 19 publications in 2020

Year	Publications
1994	1
1998	2
1999	1
2001	4
2002	1
2003	5
2004	6
2005	5
2006	11
2007	6
2008	2
2009	7
2010	12
2011	12
2012	10
2013	5
2014	10
2015	10
2016	11
2017	15
2018	17
2019	16
2020	19
2021	15
2022	14

Tweets by vsanchorawala

Twitter likes by vsanchorawala

Facebook Live

There’s New Proof Crispr Can Edit Genes Inside Human Bodies

WIRED 9/22/2022

Young Black Patients With AML Face Significantly Worse Outcomes

Oncology Times 8/5/2022

Stem Cell Transplantation Shows Promise in AL Amyloidosis

Global Genes 7/20/2022

Stem cell transplantation produces prolonged survival with improved safety in patients with AL amyloidosis

News Medical 7/14/2022

Stem cell transplantation for AL amyloidosis leads to long-term survival and possible cure in selected patients

Medical Xpress 7/14/2022

Dr. Sanchorawala on the Impact of Depth of Renal and Cardiac Response on Survival in AL Amyloidosis

Onc Live 9/10/2021

Honoring 20 Outstanding Women, Woman of the Year 2021 and Lifetime Achievement Award Video Released

India New England News 3/25/2021

Vaishali Sanchorawala: Her Pioneering Research Into the Rare Disease Amyloidosis Defines the Field

India New England 2/24/2021

18th Annual Woman of the Year Awards Gala Postponed Until Next Spring: April 30

INDIA New England News 9/3/2020

Daratumumab Safe And Effective Option For Treating Light Chain (AL) Amyloidosis

Medical Dialogues 2/4/2020

2015 Research mentor award

2015 Schwartz Center for Compassionate Healthcare: Compassionate Caregiver Award

2011 Research Mentoring Award nomination

2011 Schwartz Center for Compassionate Healthcare: Compassionate Caregiver Award

2007-2009 Robert Dawson Evans Clinician Award

2000 IBMTR/ABMTR: Mortimer M. Bortin Award for best abstract

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Amyloidosis [C18.452.845.500]
Stem cell transplantation
Clinical research
QoL

Available to Mentor as: (Review Mentor Role Definitions):